Moderna will test an additional booster dose of its COVID-19 Vaccine (mRNA-1273) to investigate its ability to further boost the immune response against the variants.
In total, therefore, the doses to be used, once this trial is completed, would become 3. This was announced by the company announcing the effectiveness of the vaccine against the GB and South African variants.
"As we seek to defeat the COVID-19 virus, which caused the pandemic, we believe it is crucial to be proactive as the virus evolves," said Stéphane Bancel, Moderna's Chief Executive Officer.
First Pfizer doses arrived, by Wednesday 455 thousand
- The first vials of the approximately 455 thousand doses of Pfizer vaccine scheduled for this week for Italy are arriving in various regions, after the cuts announced by the American pharmaceutical company. Pfizer doses should be delivered by Wednesday while tomorrow the 66 thousand of Moderna vaccine destined for Italy should arrive this week. According to what is learned, today Pfizer should send about 31,500 doses while the most consistent deliveries are expected for tomorrow, about 406 thousand from Pfizer and 66 thousand from Moderna. Finally, on Wednesday, the last 17,000 doses should arrive on Wednesday.
